If you have certain types of arthritis or plaque psoriasis, your doctor may prescribe Enbrel. It’s used to treat the following conditions: Enbrel contains the active drug etanercept, which is a ...

Doctors prescribe Enbrel for arthritis, psoriasis, and other conditions. The medication can cause side effects that are mild and some serious ones. Serious side effects of Enbrel include neurologic ...

SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...

The needle stays hidden during injection and a sensor can detect placement on skin. It also includes 3 difference injection speeds, a progress bar and a speaker. Amgen announced the availability of ...

The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...

Enbrel (etanercept) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat multiple types of inflammatory conditions. Read on to learn about how much ...

THOUSAND OAKS, Calif., November 12, 2006 -- Amgen (NASDAQ: AMGN) today announced that Enbrel? (etanercept) is the first biologic with published data to show improvements in multiple measures of ...

Whether starting or maintaining treatment, the Embark App has multiple features that can help patients on ENBREL throughout their treatment experience. As the healthcare industry continues to evolve ...

Americans with psoriasis and rheumatoid arthritis will have to wait much longer for low-priced copycat versions of their weekly Enbrel injections. Amgen (AMGN 1.17%) won an appeals court ruling on ...

Enbrel (etanercept) is a prescription brand-name medication. It’s approved by the Food and Drug Administration (FDA) to treat the following conditions: For each of these conditions, Enbrel is ...

Americans with psoriasis and rheumatoid arthritis will have to wait much longer for low-priced copycat versions of their weekly Enbrel injections. Amgen (NASDAQ: AMGN) won an appeals court ruling on ...